In Denmark Valcon Medical has completed the acquisition of fellow Danish company ScanLeaf, a processor and distributor of medical cannabis products.
The ScanLeaf acquisition provides Valcon with processing and distribution facilities in Denmark which it will leverage to support its growing Scandinavian medical cannabis business.
Pete Patterson, Chief Executive Officer of Valcon, said: “The ScanLeaf team brings a level of product knowledge and market expertise that aligns with Valcon’s primary value: a focus on quality above all else.”
Hasse Herlevsen, CEO and co-founder of Scanleaf said :“Not only will the merger create significant revenue and cost synergies for Valcon Medical, but the combined company will be unmatched in capability and reach as a full-scale service medical cannabis operator in Denmark.
“By merging Scanleaf and Valcon Medical we are providing the market with a strong supply chain partner focused on delivering profitable growth while serving the best interests of medical cannabis patients across Europe.”
Valcon Medical produces whole-plant, medical products under EU GMP standards and sold into the global medical cannabis market.
Germany Seeing Sense, High Tide Strikes Deal With Major German Player, European Expansion For Bedrocan, Danish Buy-Out, Greek First, £2m UK Hemp Boost